scispace - formally typeset
G

Guillermo Barreto

Researcher at Max Planck Society

Publications -  65
Citations -  3486

Guillermo Barreto is an academic researcher from Max Planck Society. The author has contributed to research in topics: Chromatin & Biology. The author has an hindex of 21, co-authored 52 publications receiving 2850 citations. Previous affiliations of Guillermo Barreto include Paris 12 Val de Marne University & University of Giessen.

Papers
More filters
Journal ArticleDOI

Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones

TL;DR: Data reveal the important role of protein components in NET, particularly histones, which may lead to host cell cytotoxicity and may be involved in lung tissue destruction.
Journal ArticleDOI

Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation

TL;DR: It is shown that Gadd45a (growth arrest and DNA-damage-inducible protein 45 alpha), a nuclear protein involved in maintenance of genomic stability, DNA repair and suppression of cell growth, has a key role in active DNA demethylation.
Journal ArticleDOI

Nuclear reprogramming of human somatic cells by Xenopus egg extract requires BRG1

TL;DR: Nuclear reprogramming of permeabilized human cells using extracts from Xenopus laevis eggs and early embryos is demonstrated and upregulation of pluripotency markers Oct-4 and germ cell alkaline phosphatase (GCAP) in 293T cells and human primary leukocytes is shown.
Journal ArticleDOI

Transcriptional repression by the insulator protein CTCF involves histone deacetylases

TL;DR: It is suggested that CTCF driven repression is mediated in part by the recruitment of histone deacetylase activity by SIN3A, a candidate tumor suppressor protein that binds to highly divergent DNA sequences.
Journal ArticleDOI

Epigenetics in lung cancer diagnosis and therapy

TL;DR: This review summarizes the chromatin alterations in lung cancer, focusing on the diagnostic and therapeutic approaches targeting epigenetic modifications that could help to reduce the high case-fatality rate of this dreadful disease.